Your browser doesn't support javascript.
loading
Pyruvate carboxylase deficiency: An underestimated cause of lactic acidosis.
Habarou, F; Brassier, A; Rio, M; Chrétien, D; Monnot, S; Barbier, V; Barouki, R; Bonnefont, J P; Boddaert, N; Chadefaux-Vekemans, B; Le Moyec, L; Bastin, J; Ottolenghi, C; de Lonlay, P.
Afiliação
  • Habarou F; Centre de Référence des Maladies Héréditaires du Métabolisme, Hôpital Necker, APHP, Paris, France.
  • Brassier A; INSERM U1124, Université Paris Descartes, Paris, France.
  • Rio M; Service de Biochimie Métabolomique et Protéomique, Hôpital Necker, APHP, Paris, France.
  • Chrétien D; Centre de Référence des Maladies Héréditaires du Métabolisme, Hôpital Necker, APHP, Paris, France.
  • Monnot S; Université Paris Descartes, Paris, France.
  • Barbier V; Département de Génétique, Hôpital Necker, APHP, Paris, France.
  • Barouki R; INSERM U781, Paris, France.
  • Bonnefont JP; Département de Génétique, Hôpital Necker, APHP, Paris, France.
  • Boddaert N; IHU Imagine, UMR1163, France.
  • Chadefaux-Vekemans B; Centre de Référence des Maladies Héréditaires du Métabolisme, Hôpital Necker, APHP, Paris, France.
  • Le Moyec L; Centre de Référence des Maladies Héréditaires du Métabolisme, Hôpital Necker, APHP, Paris, France.
  • Bastin J; INSERM U1124, Université Paris Descartes, Paris, France.
  • Ottolenghi C; Service de Biochimie Métabolomique et Protéomique, Hôpital Necker, APHP, Paris, France.
  • de Lonlay P; Département de Génétique, Hôpital Necker, APHP, Paris, France.
Mol Genet Metab Rep ; 2: 25-31, 2015 Mar.
Article em En | MEDLINE | ID: mdl-28649521
ABSTRACT
Pyruvate carboxylase (PC) is a biotin-containing mitochondrial enzyme that catalyzes the conversion of pyruvate to oxaloacetate, thereby being involved in gluconeogenesis and in energy production through replenishment of the tricarboxylic acid (TCA) cycle with oxaloacetate. PC deficiency is a very rare metabolic disorder. We report on a new patient affected by the moderate form (the American type A). Diagnosis was nearly fortuitous, resulting from the revision of an initial diagnosis of mitochondrial complex IV (C IV) defect. The patient presented with severe lactic acidosis and pronounced ketonuria, associated with lethargy at age 23 months. Intellectual disability was noted at this time. Amino acids in plasma and organic acids in urine did not show patterns of interest for the diagnostic work-up. In skin fibroblasts PC showed no detectable activity whereas biotinidase activity was normal. We had previously reported another patient with the severe form of PC deficiency and we show that she also had secondary C IV deficiency in fibroblasts. Different anaplerotic treatments in vivo and in vitro were tested using fibroblasts of both patients with 2 different types of PC deficiency, type A (patient 1) and type B (patient 2). Neither clinical nor biological effects in vivo and in vitro were observed using citrate, aspartate, oxoglutarate and bezafibrate. In conclusion, this case report suggests that the moderate form of PC deficiency may be underdiagnosed and illustrates the challenges raised by energetic disorders in terms of diagnostic work-up and therapeutical strategy even in a moderate form.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article